Pfizer: Levoxyl (levothyroxine Sodium Tablets, Usp), Tablets, 175 Mcg, 100 Tablet Bottle
Levoxyl (levothyroxine) 175 mcg Recall Summary Pfizer is recalling Levoxyl levothyroxine sodium tablets in 175 mcg strength (100-tablet bottles, NDC 60793-859-01) distributed nationwide and in Puerto Rico because the medication was found to contain less active ingredient than specified. This issue was discovered during stability testing. Patients in all U.S. states and territories who have this specific product should contact their healthcare provider or pharmacist.
- Recalling firm
- Pfizer
- Product
- Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-01.
- Reason
- Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-09-29
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- US Nationwide and Puerto Rico
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/83a91fc5-2129-45a7-b623-36868c937d1e